Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults. - Koram KA; Walker KA; Orizu B; Marrero I; Boyer J; Yang S; Broderick KE; Kusi KA; Kyei-Baafour E; Ofori EA; Pobee A; Adu-Amankwah S; et al. (Frontiers in immunology, 2025)